Quidel | QDEL - مصاريف البيع والإدارة





مصاريف البيع والإدارة تغيير تاريخ
Abbott USD 3.27B 138M 2026-03
Agilent USD 476M 48M 2025-12
Avanos Medical USD 78.8M 1.2M 2025-12
Becton, Dickinson and Co. USD 1.39B 27M 2025-12
Bruker USD 247.2M 4.7M 2025-12
Cerus USD 19.33M 1.55M 2024-12
Charles River Laboratories USD 196.14M 18.55M 2025-12
Danaher USD 1.86B 166M 2026-03
Haemonetics USD 109.15M 7.54M 2025-12
Illumina USD 283M 27M 2025-12
IQVIA Holdings USD 468M 46M 2025-12
Merit Medical Systems USD 114.83M 7.45M 2025-12
Mettler Toledo International USD 259.83M 11.43M 2025-12
Myriad Genetics USD 122.3M 6.7M 2025-12
Neogen USD 98.5M 9M 2025-12
OraSure Technologies USD 13.21M 3.29M 2025-12
Pacific Biosciences Of California USD 37.24M 25.68M 2025-12
Quidel USD 194.4M 7.5M 2025-12
Revvity USD 251.73M 9.82M 2025-12
STAAR Surgical USD 38.94M 20.44M 2025-12
Thermo Fisher Scientific USD 1.98B 182M 2025-12
Waters USD 240.01M 25.78M 2025-12